Adults under 55 were least likely to be screened Colorectal cancer According to a new study published on June 29, for the past 20 years, especially if you are Hispanic or Asian, low-income, low-educated, or without health insurance. Cancer epidemiology, biomarkers and prevention..
The findings raise concerns that screening rate inequality will be even greater in adults aged 45 to 49 years, and need to increase awareness and outreach to make screening accessible to underserved groups. Encourages sex.
“Differences in prevalence of screening by race, ethnicity, academic background, household income, and health insurance were most pronounced between the ages of 50 and 54, but older people showed a significant increase in prevalence across these groups. I experienced it. ” Po Hung Liu, MD, MPH, Harvard clinical researcher, and his colleagues. “The persistent and exacerbating inequality observed in adults aged 50 to 54 can widen from age 45 to age 49, which is the subject of screening.”
The US Preventive Services Task Force changed the May 2021 colorectal cancer screening recommendations five years ago, screening from 45 instead of 50, which is consistent with the recommendations made by the Camaro for a Cause three years ago. Advised people to get started.
Studies show that both tissues have an increased incidence of colorectal cancer in adults younger than 50 years, and that starting screening at age 45 reduces the number of cases, reduces mortality, and increases survival. I made a change.
“Participation in colorectal cancer screening is below national goals across all age groups, and the benefits of screening are not equally realized across populations,” the senior author said. Katelyn Murphy, PhD, MPH, Associate Professor of the UT Health School of Public Health in Houston, Texas, said in a prepared statement. “Extending screening to younger ages is meticulous so that efforts to close colorectal screening and outcome disparities are not adversely affected or jeopardize efforts to increase screening initiations in unscreened older people. You need to pay attention. “
Data analyzed from 8 years over 20 years
Researchers have analyzed data from the CDC’s National Health Interview Survey over the last 20 years, eight years (2000, 2003, 2005, 2008, 2010, 2013, 2015, 2018).
The number of participants each year ranged from a minimum of 21,781 in 2008 to a maximum of 34,557 in 2013. After excluding participants who lacked information on colorectal cancer history or screening, the total population sample included 80,220 participants aged 50-75 years.
Researchers considered a person to be screened if they took at least one recommended screening test within the year being investigated, regardless of why they took the test.
Recommended tests include sigmoidoscopy. Colon endoscopy, And fecal-based testing for all survey years. In addition, the 2010, 2015, and 2018 surveys included CT colonography, and the 2018 survey included FIT-DNA.
Screening for the entire population group
The screening rate for colorectal cancer has doubled in the last 20 years from 36.7% in 2000 to 66.1% in 2018.
However, prices are considerably lower in some major groups, including the youngest group. Less than half (47.6%) of people aged 50-54 were screened in 2018, an improvement of nearly 20 points over the 28.2% of this age group screened in 2000.
Apart from age, some other groups are common, such as Hispanic (56.5%, up from 25.9% in 2000), Asians (57.1%, up from 22.6% in 2000), and people who haven’t received highs. School degrees (53.6%, up from 26.8% in 2000), and low-income households (56.6%, up from 30.2% in 2000).
The group with the highest need for more outreach and screening is uninsured people, with only 39.7% screened in 2018, a slight increase from 30.2% in 2000.
The largest increase in screening over time occurred between the ages of 70 and 75 and increased overall from 46.4% in 2000 to 78% in 2018.
Gap based on race / ethnicity, economy, education, and insurance was especially evident in young people, including progress over time.
For example, screening for non-Hispanic whites aged 50-54 years between 2000 and 2018 compared to 19 points (16.7% -35.7%) for Hispanics and 15 points (17.3%) for Asians. It improved by 21 points (30.3% -51%). ~ 32.3%). Fortunately, black Americans have made even greater progress than white Americans, with an increase of 27 points (23.4% to 50%) in the meantime.
Similarly, income correlated with increased screening rates for ages 50-54. Those who earned at least 400% on the federal poverty line improved by 20 points (33.5% to 53.5%) compared to a 16-point improvement. Those who are below the poverty line by less than 200% (19.3% to 35%).
People with private insurance also improved by 21 points (30.7% to 51.7%), but those in this age group without insurance decreased, screening only 21.2% in 2018 compared to 28.2% in 2000. Was not done. Point improvement from 27.8% in 2000 to 42.8% in 2018.
“The personal and social burden of colorectal cancer is high, especially among young adults,” the author writes.
The authors found that the prevalence of screening for people under the age of 55 is much lower because of less concern for colorectal cancer and less access to health care (uninsured or insured). It suggests that it is likely due to barriers created by conflicting priorities (including those that have not been). As a work schedule, family responsibilities, and care. The latter may be particularly applicable to underserved populations, the authors said.
“The screening program needs to take into account the barriers inherent in young adults and ensure that the benefits of screening are equally realized by all population groups,” the authors conclude.
This study was funded by the National Institutes of Health and the Texas Cancer Prevention Institute. One author reported grants from Epigenomics and Freenome and personal fees from Guardant Health. Another author reported personal charges from Freenome, and a third author reported personal charges from Exact Sciences.Other authors do not disclose the industry ..
Cancer epidemiol biomarker prev.. Published online on June 29, 2022. DOI: 10.1158 / 1055-9965.EPI-21-1330.
Tara Haelle is a Dallas-based science journalist. Follow her @Tarahare.
Follow Medscape for more news. Facebook, twitter, Instagram, YouTubeWhen LinkedIn.
